🔗 Share this article

The Nobel Prize in medical science has been awarded for revolutionary discoveries that illuminate how the body's defense network targets harmful pathogens while protecting the healthy tissues.

A trio of renowned researchers—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

Their work uncovered specialized "security guards" within the immune system that remove rogue immune cells that could attacking the body.

These discoveries are now paving the way for innovative therapies for immune disorders and malignancies.

These laureates will share a prize fund valued at 11m Swedish kronor.

Crucial Discoveries

"The work has been essential for comprehending how the body's defenses operates and the reason we don't all suffer from serious self-attack conditions," commented the chair of the award panel.

This trio's studies address a core mystery: How does the immune system protect us from countless infections while leaving our own tissues intact?

The body's protection system uses immune cells that scan for signs of infection, including viruses and germs it has never encountered.

Such cells employ detectors—known as receptors—that are generated randomly in countless variations.

This gives the defense network the capacity to fight a broad range of invaders, but the unpredictability of the mechanism inevitably creates immune cells that can attack the host.

Protectors of the Immune System

Researchers previously knew that some of these harmful white blood cells were eliminated in the immune organ—the site where immune cells develop.

This year's Nobel Prize honors the identification of regulatory T-cells—known as the body's "peacekeepers"—which patrol the system to disarm other defenders that attack the body's own tissues.

We know that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.

A Nobel panel stated, "These findings have laid the foundation for a novel area of investigation and accelerated the development of new therapies, for example for tumors and autoimmune diseases."

In malignancies, T-regs prevent the system from attacking the growth, so studies are aimed at reducing their quantity.

In autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is not being harmed. A comparable method could also be effective in reducing the chances of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, from Osaka University, performed experiments on rodents that had their thymus extracted, causing self-attack conditions.

He showed that introducing defense cells from other animals could prevent the illness—implying there was a system for preventing defenders from harming the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an genetic autoimmune disease in rodents and humans that led to the discovery of a genetic factor vital for how regulatory T-cells operate.

"Their groundbreaking work has uncovered how the immune system is controlled by T-reg cells, stopping it from mistakenly targeting the healthy cells," commented a leading biological science specialist.

"The research is a remarkable example of how fundamental physiological research can have broad consequences for public health."